Literature DB >> 17468918

Prognostic value of preoperative peripheral blood monocyte count in patients with colorectal liver metastasis after liver resection.

Atsushi Sasaki1, Seiichiro Kai, Yuichi Endo, Kentaro Iwaki, Hiroki Uchida, Masayuki Tominaga, Ryoki Okunaga, Kohei Shibata, Masayuki Ohta, Seigo Kitano.   

Abstract

Prognostic values of leukocyte subset counts in peripheral blood of cancer patients have not yet been fully investigated. We retrospectively examined the relation between preoperative absolute counts of peripheral blood leukocyte subsets and clinicopathologic factors and long-term prognosis in 97 patients with liver metastasis from colorectal cancer who underwent hepatic resection. Median preoperative peripheral blood leukocyte subset counts were as follows: neutrophils 3148/mm3; lymphocytes 1574/mm3; monocytes 380/mm3. Univariate analysis indicated significantly worse 5-year cancer-related survival for patients with a peripheral blood monocyte count >300/mm3 (67.5%) than for patients with a count <or=300/mm3 (36.8%). Multivariate analysis showed a preoperative peripheral blood monocyte count >300/mm3 and preoperative CEA level (>10 ng/ml) to be independent predictive factors for cancer-related survival after hepatic resection. The preoperative peripheral monocyte count correlated positively with white blood cell and neutrophil counts, but not with the tumor number, interval between colorectal and hepatic surgery, or preoperative serum CEA level. Our findings indicate that a preoperative absolute peripheral blood monocyte count >300/mm3 is an independent predictive factor for cancer-related survival of patients with colorectal liver metastasis who have undergone hepatic resection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17468918     DOI: 10.1007/s11605-007-0140-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.267


  27 in total

1.  Natural killer cell activity in patients with hepatocellular carcinoma: a new prognostic indicator after hepatectomy.

Authors:  A Taketomi; M Shimada; K Shirabe; K Kajiyama; T Gion; K Sugimachi
Journal:  Cancer       Date:  1998-07-01       Impact factor: 6.860

2.  Five-year cancer cure: relation to total amount of peripheral lymphocytes and neutrophils.

Authors:  A Riesco
Journal:  Cancer       Date:  1970-01       Impact factor: 6.860

3.  Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma.

Authors:  Atsushi Sasaki; Yukio Iwashita; Kohei Shibata; Toshifuni Matsumoto; Masayuki Ohta; Seigo Kitano
Journal:  Surgery       Date:  2006-06       Impact factor: 3.982

4.  Potent stimuli combined with lipopolysaccaride and IFNgamma may improve immunotherapy against HCC by increasing the maturation and subsequent immune response of the dendritic cells.

Authors:  Yukio Iwashita; Shigeru Goto; Kouichirou Tahara; Katsunori Kawano; Chao-Long Chen; Seigo Kitano
Journal:  Cancer Biother Radiopharm       Date:  2003-02       Impact factor: 3.099

5.  The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4+ CD25- T cells.

Authors:  Ellen Kreijveld; Hans J P M Koenen; Luuk B Hilbrands; Hans J P van Hooff; Irma Joosten
Journal:  Blood       Date:  2006-08-10       Impact factor: 22.113

6.  Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group.

Authors:  H J Nielsen; I J Christensen; S Sørensen; F Moesgaard; N Brünner
Journal:  Ann Surg Oncol       Date:  2000-09       Impact factor: 5.344

7.  Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.

Authors:  F O Nestle; S Alijagic; M Gilliet; Y Sun; S Grabbe; R Dummer; G Burg; D Schadendorf
Journal:  Nat Med       Date:  1998-03       Impact factor: 53.440

8.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

9.  Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.

Authors:  T Takahashi; Y Kuniyasu; M Toda; N Sakaguchi; M Itoh; M Iwata; J Shimizu; S Sakaguchi
Journal:  Int Immunol       Date:  1998-12       Impact factor: 4.823

Review 10.  Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy.

Authors:  A M Abulafi; N S Williams
Journal:  Br J Surg       Date:  1994-01       Impact factor: 6.939

View more
  25 in total

1.  Prognostic significance of the preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer.

Authors:  Masatsune Shibutani; Kiyoshi Maeda; Hisashi Nagahara; Yasuhito Iseki; Tetsuro Ikeya; Kosei Hirakawa
Journal:  Oncol Lett       Date:  2016-12-12       Impact factor: 2.967

2.  Immunological markers predict the prognosis of patients with squamous non-small cell lung cancer.

Authors:  Long Jiang; Zerui Zhao; Shanshan Jiang; Yongbin Lin; Han Yang; Zehua Xie; Yaobin Lin; Hao Long
Journal:  Immunol Res       Date:  2015-07       Impact factor: 2.829

3.  Prognostic significance of preoperative peripheral blood monocyte ratio in patients with hepatocellular carcinoma.

Authors:  Seung Duk Lee; Seong Hoon Kim; Young-Kyu Kim; Soon-Ae Lee; Sang-Jae Park
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

4.  The Angiotensin Receptor Blocker Losartan Suppresses Growth of Pulmonary Metastases via AT1R-Independent Inhibition of CCR2 Signaling and Monocyte Recruitment.

Authors:  Daniel P Regan; Jonathan W Coy; Kirti Kandhwal Chahal; Lyndah Chow; Jade N Kurihara; Amanda M Guth; Irina Kufareva; Steven W Dow
Journal:  J Immunol       Date:  2019-04-10       Impact factor: 5.422

5.  Peripheral blood monocyte counts are elevated in the pre-diagnostic phase of pancreatic cancer: A population based study.

Authors:  Jaime de la Fuente; Ayush Sharma; Suresh Chari; Shounak Majumder
Journal:  Pancreatology       Date:  2019-10-10       Impact factor: 3.996

6.  Full blood count pattern of pre-chemotherapy breast cancer patients in Lagos, Nigeria.

Authors:  Akinsegun Akinbami; Abiodun Popoola; Adewumi Adediran; Adedoyin Dosunmu; Olajumoke Oshinaike; Philip Adebola; Sarah Ajibola
Journal:  Caspian J Intern Med       Date:  2013

7.  Role of monocyte recruitment in hemangiosarcoma metastasis in dogs.

Authors:  D P Regan; A Escaffi; J Coy; J Kurihara; S W Dow
Journal:  Vet Comp Oncol       Date:  2016-10-25       Impact factor: 2.613

8.  Prognostic value of preoperative mean corpuscular volume in esophageal squamous cell carcinoma.

Authors:  Yu-Zhen Zheng; Shu-Qin Dai; Wei Li; Xun Cao; Yong Li; Lan-Jun Zhang; Jian-Hua Fu; Jun-Ye Wang
Journal:  World J Gastroenterol       Date:  2013-05-14       Impact factor: 5.742

9.  Prognostic impact of preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer with special reference to myeloid-derived suppressor cells.

Authors:  Tatsuo Shimura; Masahiko Shibata; Kenji Gonda; Suguru Hayase; Wataru Sakamoto; Hirokazu Okayama; Shotaro Fujita; Motonobu Saito; Tomoyuki Momma; Shinji Ohki; Koji Kono
Journal:  Fukushima J Med Sci       Date:  2018-07-14

10.  The prognostic significance of the preoperative full blood count after resection of colorectal liver metastases.

Authors:  K Dajani; D A O'Reilly; N De Liguori Carino; P Ghaneh; G Poston; A Wu
Journal:  HPB Surg       Date:  2009-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.